Pilot immunotherapy trial in high-risk pediatric sarcomas.
/in Dendritic Cells, Soft Tissue Sarcoma /von 2011-06-05 / J Clin Oncol 29: 2011 (suppl; abstr 9541)Melanoma patients treated with dendritic cell vaccination, interleukin-2, and metronomic cyclophosphamide: Results from a phase II trial.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr e13084)A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 2533)Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 3557)Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers
/in Dendritic Cells, International Publications /von 2011-06-03 / Cancer Immunol. Immunother. 2011 Oct;60(10):1397-403Cancer stem cells: perspectives of new therapeutical approaches for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2011-06-01 / Front Biosci (Schol Ed) 2011 Jun;3:1486-99Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-06-01 / Clin. Cancer Res. 2011 Jul;17(14):4705-18PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2011-06-01 / J. Immunother. 2011 Jun;34(5):409-18Immunotherapy for the treatment of prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-05-24 / Nat Rev Clin Oncol 2011 May;8(9):551-61
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution